Delius Group, parent to Delius Pharmaceuticals Pvt. Ltd, is transforming Mumbai`s pharma market with its direct distribution model across India`s top 20 cities. dispatched Goods worth ₹50 crore to ₹100 crore reports coming for b2c value.
Distributors of Delius Pharma in Mumbai have expressed positive feedback regarding the company`s smooth inventory rotation. With the onboarding of new distributors, Delius Pharma has dispatched goods worth ₹50 crore to ₹100 crore according to B2C value in the market, as reported by the All-India Pharma Mumbai Distributors Local Association.
The inventory rollouts align with Delius Pharma`s commitment to strengthening its offline presence. As the company expands, Mumbai distributors have praised the direct supply chain model, citing its efficiency and reliability.
“Delius Pharma`s direct distribution strategy not only ensures timely supply but also allows distributors to focus on promoting products more effectively,” a leading distributor in Mumbai shared.
